Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04843046
PHASE2

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Sponsor: The University of Texas Health Science Center, Houston

View on ClinicalTrials.gov

Summary

The purpose of this study is to see how well pioglitazone, when used with cognitive behavioral therapy, works at helping people who have recently stopped using cocaine to continue to not use cocaine.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

61

Start Date

2021-08-23

Completion Date

2025-10-15

Last Updated

2026-09-21

Healthy Volunteers

No

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

All participants will receive evidence-based individual Cognitive Behavioral Therapy (CBT) shown to be an effective intervention for maintaining abstinence following detoxification. Trained masters-level licensed professional counselors will deliver CBT.

DRUG

Pioglitazone

Pioglitazone capsules will start at 30 mg (Detox days 3 and 4) and increase to fixed dose of 45 mg for study weeks 1-12 and will also contain riboflavin.

DRUG

Placebo

Placebo capsules will be filled with corn starch and riboflavin.

Locations (1)

UTHealth Center for Neurobehavioral Research on Addiction

Houston, Texas, United States